These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24187689)

  • 1. Prevention of HCV replication by serine palmitoyltransferase inhibition.
    Lowe AW; Moseley RH
    Gastroenterology; 2013 Oct; 145(4):701-2. PubMed ID: 24187689
    [No Abstract]   [Full Text] [Related]  

  • 2. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.
    Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M
    Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.
    Ciesek S; Steinmann E; Manns MP; Wedemeyer H; Pietschmann T
    J Infect Dis; 2008 Oct; 198(7):1091-3. PubMed ID: 18774886
    [No Abstract]   [Full Text] [Related]  

  • 4. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
    Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
    Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued value in understanding viral kinetic decline during interferon-free therapy for HCV.
    Meissner EG
    Liver Int; 2015 Feb; 35(2):295-6. PubMed ID: 25424883
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
    Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
    Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro.
    Descamps V; Helle F; Louandre C; Martin E; Brochot E; Izquierdo L; Fournier C; Hoffmann TW; Castelain S; Duverlie G; Galmiche A; François C
    Antiviral Res; 2015 Jun; 118():93-102. PubMed ID: 25823619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine.
    King RW; Zecher M; Jefferies MW
    Antivir Chem Chemother; 2002 Nov; 13(6):363-70. PubMed ID: 12718408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
    Ikeda M; Kawai Y; Mori K; Yano M; Abe K; Nishimura G; Dansako H; Ariumi Y; Wakita T; Yamamoto K; Kato N
    Liver Int; 2011 Jul; 31(6):871-80. PubMed ID: 21645219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
    Aly HH; Shimotohno K; Hijikata M
    Biochem Biophys Res Commun; 2009 Feb; 379(2):330-4. PubMed ID: 19103167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
    Saito K; Shirasago Y; Suzuki T; Aizaki H; Hanada K; Wakita T; Nishijima M; Fukasawa M
    J Virol; 2015 Feb; 89(4):2220-32. PubMed ID: 25473062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic lipophilic antioxidant BO-653 suppresses HCV replication.
    Yasui F; Sudoh M; Arai M; Kohara M
    J Med Virol; 2013 Feb; 85(2):241-9. PubMed ID: 23192857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).
    González-Carmona MA; Quasdorff M; Vogt A; Tamke A; Yildiz Y; Hoffmann P; Lehmann T; Bartenschlager R; Engels JW; Kullak-Ublick GA; Sauerbruch T; Caselmann WH
    Antiviral Res; 2013 Jan; 97(1):49-59. PubMed ID: 23142319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication.
    Blanchet M; Seidah NG; Labonté P
    Antiviral Res; 2012 Aug; 95(2):159-66. PubMed ID: 22626636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine inhibits hepatitis C virus replication in vitro.
    Batista MN; Carneiro BM; Braga AC; Rahal P
    Arch Virol; 2015 Feb; 160(2):399-407. PubMed ID: 25491197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
    Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
    Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.